Sfoglia per Rivista CANCER CHEMOTHERAPY AND PHARMACOLOGY
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
2015 PETRIOLI, ROBERTO; Francini, Edoardo; ROVIELLO, FRANCO; MARRELLI, DANIELE; FIASCHI, ANNA IDA; LAERA, LETIZIA; ROSSI, GIULIA; Bianco, V; Brozzetti, S; ROVIELLO, GIANDOMENICO
The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate.
2007 OOSTENDORP RL; MARCHETTI S; BEJINEN JH; R. MAZZANTI; SCHELLENS JH. . MAY; -. EPUB AHEAD OF PRINT
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next
2022 D'Angelo, Alberto; Chapman, Robert; Sirico, Marianna; Sobhani, Navid; Catalano, Martina; Mini, Enrico; Roviello, Giandomenico
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience | 2015 | PETRIOLI, ROBERTO; Francini, Edoardo; ROVIELLO, FRANCO; MARRELLI, DANIELE; FIASCHI, ANNA IDA; LAERA, LETIZIA; ROSSI, GIULIA; Bianco, V; Brozzetti, S; ROVIELLO, GIANDOMENICO | |
The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate. | 2007 | OOSTENDORP RL; MARCHETTI S; BEJINEN JH; R. MAZZANTI; SCHELLENS JH. . MAY; -. EPUB AHEAD OF PRINT | |
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next | 2022 | D'Angelo, Alberto; Chapman, Robert; Sirico, Marianna; Sobhani, Navid; Catalano, Martina; Mini, Enrico; Roviello, Giandomenico |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile